Return to search

THE IMPACT OF SECONDARY LYMPHEDEMA AFTER HEAD AND NECK CANCER TREATMENT ON SYMPTOMS, FUNCTIONAL STATUS, AND QUALITY OF LIFE

Because surgery, radiation, and/or chemotherapy disrupt lymphatic structures, damage soft tissue leading to scar tissue formation and fibrosis, and further affect lymphatic function, head and neck cancer patients may be at high risk for developing secondary lymphedema. Head and neck cancer patients may develop secondary lymphedema externally (e.g., face) and internally (e.g., larynx). It not only influences patients most visible body areas (e.g., face and neck), but it also impacts critical physical functions (e.g., breathing and swallowing). These issues are understudied. The possible factors contributing to secondary lymphedema after head and neck cancer are unknown.
The study was conducted to examine the associations among the severity of lymphedema, symptoms, functional status, and quality of life in head and neck cancer patients. The study also examined the possible factors contributing to the presence of secondary lymphedema in head and neck cancer patients. A convenience sample of 103 head and neck cancer patients were recruited at the Vanderbilt-Ingram Cancer Center.
Several significant findings were generated from this study. First, the study findings suggest that lymphedema in head and neck cancer patients is a very common late-effect. The study identified that head and neck cancer patients may not only develop external lymphedema (such as facial and neck area), but also have internal lymphedema (such as pharynx and larynx) after their cancer treatment. The findings from this study demonstrated that the severity of lymphedema was statistically significantly associated with swallowing difficulty, mucous/dry mouth-related symptoms, and impaired body image. The study found that the severity of combined (internal and external) lymphedema was statistically significantly associated with head and neck cancer patients quality of life status. In addition, the study found that types and dosages of cancer treatment were statistically significantly associated with whether or not head and neck cancer patients presented with lymphedema. Thus, the study provides an insight regarding the importance of addressing lymphedema in head and neck cancer patients.

Identiferoai:union.ndltd.org:VANDERBILT/oai:VANDERBILTETD:etd-07292010-081826
Date05 August 2010
CreatorsDENG, JIE
ContributorsSheila H. Ridner, Mary S. Dietrich, Barbara A. Murphy, Kenneth A. Wallston, Nancy Wells
PublisherVANDERBILT
Source SetsVanderbilt University Theses
LanguageEnglish
Detected LanguageEnglish
Typetext
Formatapplication/pdf
Sourcehttp://etd.library.vanderbilt.edu/available/etd-07292010-081826/
Rightsunrestricted, I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to Vanderbilt University or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report.

Page generated in 0.2942 seconds